For neuroradiologists, the Signa Magnus 3T MRI system may offer enhanced visualization of the brain microstructure, microvasculature, and function.
Offering a combination of advanced gradient technology, deep-learning algorithms and short echo times, GE HealthCare is showcasing the new Signa Magnus 3T MRI at the International Society for Magnetic Resonance in Medicine (ISMRM) Annual Meeting in Singapore, Asia.
Featuring a gradient strength of 300 mT/m and slew rate of 750 T/m/s, the Signa Magnus is dedicated to head-only MRI imaging and reportedly provides enhanced imaging detail of the brain’s function, microstructure, and microvasculature, according to GE HealthCare.
Reportedly offering enhanced imaging detail of the brain’s function, microstructure, and microvasculature, the head-only 3T MRI system Signa Magnus provides higher b-value diffusion with short echo times, according to GE HealthCare, the manufacturer of the device. (Photo courtesy of GE HealthCare.)
In addition to deep-learning algorithms to bolster advanced imaging techniques, the company said another key attribute of the Signa Magnus MRI system is the capability to achieve higher b-value diffusion with short echo times.
"With Signa Magnus, we are not just exploring the possibility of providing the tool; we are setting new benchmarks in medical research and future clinical patient care.” said Kelly Londy, the chief executive officer of MR for GE HealthCare. “This innovation underscores our commitment to R&D and our collaborations with academia, pushing the boundaries of what's possible in MR imaging. The potential impact of Signa Magnus on patient outcomes and our understanding of the human brain is profound."
GE HealthCare noted that the Signa Magnus system is pending 510(k) clearance from the Food and Drug Administration (FDA).
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
New AI-Enabled Portable Ultrasound May Facilitate 50 Percent Reduction in Cardiac Imaging Scan Time
March 28th 2025Artificial intelligence (AI)-powered measurement capabilities provide key features with the Compact Ultrasound 5500CV device, which was unveiled at the American College of Cardiology (ACC) conference.
GE HealthCare Launches PET MPI Agent Flyrcado at ACC Conference
March 28th 2025The positron emission tomography myocardial perfusion imaging (PET MPI) agent, which offers a significantly higher half-life than other cardiac PET agents, was recently granted pass-through payment status by CMS that will go into effect on April 1, 2025.